Since its development in 1976, 18F-FDG had a profound influence on research in the neurosciences. The subsequent discovery 1980 that 18F-FDG accumulates in tumors underpins the evolution of PET as a major clinical tool in cancer diagnosis.18F-FDG is now the standard radiotracer used for PET neuroimaging and cancer patient management.